Angiodynamic Inc’s filing revealed that its SVP Quality and Regulatory Nighan Warren JR unloaded Company’s shares for reported $49979.0 on Jan 16 ’25. In the deal valued at $12.31 per share,4,060 shares were sold. As a result of this transaction, Nighan Warren JR now holds 41,817 shares worth roughly $0.41 million.
Then, Nighan Warren JR bought 4,060 shares, generating $49,979 in total proceeds.
Before that, Nighan Warren JR bought 768 shares. Angiodynamic Inc shares valued at $4,677 were divested by the SVP Quality and Regulatory at a price of $6.09 per share. As a result of the transaction, Nighan Warren JR now holds 45,777 shares, worth roughly $0.45 million.
Oppenheimer upgraded its Angiodynamic Inc [ANGO] rating to an Outperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Raymond James also remained covering ANGO and has decreased its forecast on April 17, 2023 with a “an Outperform” recommendation from previously “Strong buy” rating. Canaccord Genuity revised its rating on October 15, 2021. It rated ANGO as “a Buy” which previously was an “a Hold”.
Price Performance Review of ANGO
On Tuesday, Angiodynamic Inc [NASDAQ:ANGO] saw its stock fall -2.18% to $9.86. Over the last five days, the stock has lost -5.47%. Angiodynamic Inc shares have risen nearly 7.64% since the year began. Nevertheless, the stocks have risen 64.61% over the past one year. While a 52-week high of $13.50 was reached on 01/30/25, a 52-week low of $5.26 was recorded on 01/02/25. SMA at 50 days reached $10.59, while 200 days put it at $7.78.
Levels Of Support And Resistance For ANGO Stock
The 24-hour chart illustrates a support level at 9.63, which if violated will result in even more drops to 9.41. On the upside, there is a resistance level at 10.10. A further resistance level may holdings at 10.35. The Relative Strength Index (RSI) on the 14-day chart is 37.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.50%. Stochastics %K at 15.46% indicates the stock is a buying.
The most recent change occurred on August 20, 2021 when Oppenheimer began covering the stock and recommended ‘”a Perform”‘ rating .
